These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20107591)

  • 1. School board survey of attention deficit/hyperactivity disorder: Prevalence of diagnosis and stimulant medication therapy.
    Sgro M; Roberts W; Grossman S; Barozzino T
    Paediatr Child Health; 2000 Jan; 5(1):19-23. PubMed ID: 20107591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.
    Brault MC; Lacourse É
    Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
    CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Predictors of Medication Use in Children with Attention-Deficit/Hyperactivity Disorder: Evidence from a Community-Based Longitudinal Study.
    Efron D; Gulenc A; Sciberras E; Ukoumunne OC; Hazell P; Anderson V; Silk TJ; Nicholson JM
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):50-57. PubMed ID: 30508385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder.
    Wolraich ML; Lindgren S; Stromquist A; Milich R; Davis C; Watson D
    Pediatrics; 1990 Jul; 86(1):95-101. PubMed ID: 2359688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Stimulant Medical and Nonmedical Use Among US Secondary School Students, 2005 to 2020.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2023 Apr; 6(4):e238707. PubMed ID: 37071423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.
    Connor DF
    J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
    Robison LM; Sclar DA; Skaer TL; Galin RS
    Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG; Reece CE; Sawyer AC; Johnson S; Lawrence D; Zubrick SR
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):177-184. PubMed ID: 27154239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.
    dosReis S; Park A; Ng X; Frosch E; Reeves G; Cunningham C; Janssen EM; Bridges JFP
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):234-242. PubMed ID: 27991834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial.
    Lyon MR; Kapoor MP; Juneja LR
    Altern Med Rev; 2011 Dec; 16(4):348-54. PubMed ID: 22214254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.